Viagra (sildenafil) is primarily designed and approved for treating erectile dysfunction in men by increasing blood flow to the penis. Its effects on women have been studied, but it is not widely used or approved for enhancing sexual function in women. The results of studies on the effectiveness of Viagra in women have been mixed, with some women reporting improved arousal and lubrication, while others did not experience significant benefits. Therefore, Viagra is not generally recommended for women.
For women experiencing sexual dysfunction, a few other medications and treatments have been developed and approved.
One such medication is Addyi (flibanserin), which is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It works on neurotransmitters in the brain, specifically by increasing levels of dopamine and norepinephrine while decreasing serotonin. This can help improve sexual desire. Addyi is taken daily and can have side effects such as dizziness, sleepiness, nausea, and low blood pressure, especially if taken with alcohol.
Another option is Vyleesi (bremelanotide), which is also used to treat HSDD in premenopausal women. It is administered via injection about 45 minutes before anticipated sexual activity. Vyleesi activates melanocortin receptors, which are thought to play a role in sexual desire and arousal. Common side effects include nausea, flushing, injection site reactions, and headache.
It's important for women experiencing sexual dysfunction to consult with a healthcare provider to discuss their symptoms and explore appropriate treatment options. The underlying causes of sexual dysfunction in women can be complex and multifactorial, involving psychological, hormonal, relational, and physiological factors, so a comprehensive approach to diagnosis and treatment is often necessary.